We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
89 hedge funds and large institutions have $34.1M invested in Atara Biotherapeutics in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 30 increasing their positions, 31 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.88% less ownership
Funds ownership: 3.49% → 2.61% (-0.88%)
3% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 31
15% less call options, than puts
Call options by funds: $23K | Put options by funds: $27K
18% less funds holding
Funds holding: 109 → 89 (-20)
54% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 35
74% less capital invested
Capital invested by funds: $131M → $34.1M (-$96.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
89
Holders Change
-20
Holders Change %
-18.35%
% of All Funds
1.3%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
16
Increased
30
Reduced
31
Closed
35
Calls
$23K
Puts
$27K
Net Calls
-$4K
Net Calls Change
-$1.72M
Top Buyers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$9.39M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.39M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$2.64M |
| 4 |
Millennium Management
New York
|
+$2.42M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.95M |
Top Sellers
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
-$14.5M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$12.4M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
-$9.31M |
| 4 |
JP Morgan Chase
New York
|
-$6.04M |
| 5 |
Goldman Sachs
New York
|
-$3.3M |
